Viral Inactivation

Viral Inactivation is a bioprocess intervention that belongs to the class of viral clearance strategies, specifically defined by the deliberate disruption of viral infectivity through chemical or physical means while preserving the integrity of the biopharmaceutical product in continuous biomanufacturing systems.

661

Publications

30.8K

Citations

3K

Authors

873

Institutions

Publications per year

2017–2026

149

Authors

3K

  1. TB
    Thierry Burnouf

    Taipei Medical University, Taiwan

    11 publications · 300 citations

    11

    h-index

  2. TR
    Thomas R. Kreil

    Baxter (Austria), Austria

    9 publications · 341 citations

    9

    h-index

  3. SG
    Sanchayita Ghose

    Bristol-Myers Squibb (United States), United States

    5 publications · 195 citations

    5

    h-index

  4. ZJ
    Zheng Jian Li

    Bristol-Myers Squibb (United States), United States

    5 publications · 234 citations

    5

    h-index

  5. EB
    E.I. Budowsky

    Institute of Bioorganic Chemistry, Russia

    5 publications · 197 citations

    5

    h-index

1–5 of 3K

Venues

  1. Applied and Environmental Microbiology

    AEM · 30 publications · 2.2K citations

    24

    h-index

  2. Transfusion

    31 publications · 1.7K citations

    21

    h-index

  3. Vox Sanguinis

    22 publications · 828 citations

    17

    h-index

  4. Biologicals

    19 publications · 540 citations

    17

    h-index

  5. PubMed

    Repository · 33 publications · 721 citations

    16

    h-index

1–5